Medicine, Hematology Oncology Division

Grants

Grants per year 1995 2007 2008 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2028

• 468 Active
• 1104 Finished

Grants per year

Search results

• Prot# CRAD001N2201: An Open-Label, Single-Arm Phase II Study of RAD001 in Patients with Refractory Mantle Cell Lymphoma

  Winter, J. N.

  Novartis Pharmaceuticals Corporation

  7/22/08 → 4/5/11

  Project: Research project

• Prot# AVF3537s / NU JH0711: Phase II Trial of Bevacizumab Combined with Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma

  Mulcahy, M. F.

  Genentech, Inc.

  4/11/08 → 4/11/11

  Project: Research project

• Prot# Perifosine 212: An Open-Label Phase II Study of the Safety and Efficacy of Perifosine Alone and in Combination with Dexamethasone for Patients with Relapsed or Relapsed/Refractory Multiple Myeloma

  Singhal, S.

  AOI Pharmaceuticals, Inc.

  5/3/06 → 5/3/11

  Project: Research project

• Prot# CP12-0710: An Open Label, Multicenter, Phase 2 Study Evaluating the Safety and Efficacy of IMC-1121B as First-Line Monotherapy in Patients with Unresectable Hepatocellular Cancer

  Mulcahy, M. F.

  ImClone Systems Incorporated

  5/8/08 → 5/8/11

  Project: Research project

• Prot# ALS-357-001: Dose-Escalating, Pilot Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ALS-357 Topically Administered to Patients with Cutaneous Metastatic Melanoma

  Kuzel, T. M.

  Advanced Life Sciences Holdings, Inc.

  5/29/08 → 5/29/11

  Project: Research project

• Prot# MEL11: Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients with Metastatic Melanoma

  Kuzel, T. M.

  Sanofi Pasteur Limited

  6/1/08 → 6/1/11

  Project: Research project

• Prot# 265: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion in Combination with Corticosteroids for the Treatment of Newly Diagn

  Mehta, J.

  Quintiles, Inc., Osiris Therapeutics, Inc.

  6/5/08 → 6/5/11

  Project: Research project

• Prot# CC-5013-MM-009: A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Study of CC-5013 Plus Dexamethasone versus Dexamthasone Alone in Previously Treated Subjects with Multiple Myeloma

  Singhal, S.

  Celgene Corporation

  4/23/03 → 6/30/11

  Project: Research project

• Prot# CC-5013-CLL-002: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid) as Maintenance Therapy for Patients with B-Cell Chronic Lymphocytic Leukemia Following

  Frankfurt, O.

  Celgene Corporation

  6/14/10 → 6/30/11

  Project: Research project

• Prot# NU 07H4: Pilot Study of Pegylated Interferon-Alfa 2B in Combination with PUVA Therapy in Cutaneous T-Cell Lymphoma

  Kuzel, T. M.

  Schering-Plough Corporation

  7/18/08 → 7/18/11

  Project: Research project

• Prot# CLO34100405: A Phase III Randomized, Double-Blind, Controlled Study Comparing Clofarabine and Cytarabine versus Cytarabine Alone in Adult Patients 55 Years and Older with Acute Myelogenous Leukemia (AML) Who Have Relapsed or are Refractory after Rec

  Frankfurt, O.

  Genzyme Corporation

  7/21/08 → 7/21/11

  Project: Research project

• Prot# G040148: TheraSphere for the Treatment of Liver Metastases: An Open Label Trail of TheraSphere in Patients with Liver Metastases from Primary Colorectal Cancer, Neuroendocrine Cancer or Non-Colorectal/Non-Neuroendocrine Cancer

  Mulcahy, M. F.

  MDS Pharma Services, MDS Nordion

  8/1/06 → 8/1/11

  Project: Research project

• Prot# ACF4325g: An Open-Label, Phase Ib Study of the Safety, Pharmacokinetics, and Activity of the Anti-CD40 Monoclonal Antibody SGN-40 Administered in Combination with Rituximab in Patients with CD20-Positive, Follicular and Marginal Zone B-Cell Non-Hodg

  Winter, J. N.

  Genentech, Inc.

  8/4/08 → 8/4/11

  Project: Research project

• Prot# H6Q-MC-JCCB: A Phase 2, Open-Label, Multicenter Study of Single-Agent Enzastaurin in Patients with Relapsed Cutaneous T-Cell Lymphoma

  Kuzel, T. M.

  Eli Lilly and Company

  8/8/08 → 8/8/11

  Project: Research project

• Prot# I1Y-MC-JFBC: A Phase 1 Study of LY2523355 in Patients with Acute Leukemia

  Frankfurt, O.

  Lilly Research Laboratories

  8/22/08 → 8/22/11

  Project: Research project

• 8th Joint Conference of the International Cytokine Society (ICS) and International Society for Interferon and Cytokine Research (ISICR)

  Platanias, L. C.

  National Cancer Institute

  9/1/10 → 8/31/11

  Project: Research project

• Role of Survivin in Development of Megakaryocytes and Erythroid Cells

  Crispino, J. D.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/21/09 → 8/31/11

  Project: Research project

• Nanomaterials for Cancer Diagnostics and Therapeutics

  Mirkin, C. A., Backman, V., Dravid, V. P., Gradishar, W. J., Kibbe, M. R., Lee, C., Meade, T. J., Nguyen, S., O'Halloran, T. V., Odom, T. W., Paunesku, T., Rademaker, A. W., Schatz, G. C., Scheidt, K. A., Singhal, S., Stupp, S., Van Duyne, R. P., Woloschak, G. E., Woodruff, T. K. & Zoloth, L. S.

  National Cancer Institute

  9/30/05 → 8/31/11

  Project: Research project

  • nanotechnology 100%
  • nanomaterials 67%
  • neoplasms 65%
  • therapeutics 39%
  • funding 18%

• Research on Adverse Drug Events and Reports: Novel Multiple Myeloma Drugs

  West, D. P., Belknap, S. M., Kuzel, T. M., Kwaan, H. C., McKoy, J. M., Mehta, J. & Singhal, S.

  National Cancer Institute

  9/6/07 → 8/31/11

  Project: Research project

• Establishment of a positive feedback loop coupling CD44 alternative splicing to HER2 signaling to promote breast cancer metastasis

  Cheng, C.

  U.S. Army Medical Research and Materiel Command

  9/1/08 → 8/31/11

  Project: Research project

• Mechanisms of Airborne Particulate Matter Induced Thrombosis

  Budinger, G. S., Green, D., Kamp, D. W., Green, D. & Kamp, D. W.

  National Institute of Environmental Health Sciences

  9/1/06 → 8/31/11

  Project: Research project

• Prot# NU 05CC8: The Bioavailability of Topical Morphine for Pain

  Paice, J., Avram, M. J. & Krejcie, T. C.

  Hospice Pharmacia

  7/17/06 → 9/1/11

  Project: Research project

• Prot# 3129K3-101-WW: A Phase 1/2 Study of CMC-544 Administered in Combination with Rituximab in Subjects With Follicular or Diffuse Large B-Cell Non-Hodgkin's Lymphoma

  Winter, J. N.

  Wyeth

  11/17/06 → 9/1/11

  Project: Research project

• Prot# CZOL446E2352: A Prospective, Randomized, Dbl-Blind, Stratified, Placebo-Controlled, Multi-Center, 3-Arm Trial of the Continued Efficacy & Safety of Zometa(Every 4 Wks v Every 12 Wks v Placebo)in Ptnts w/Documented Bone Metastases from Bre

  Gradishar, W. J.

  Novartis Pharmaceuticals Corporation

  1/29/07 → 9/1/11

  Project: Research project

• Prot# IROF-018: Three-Arm Randomized Phase II Clinical Study of Irofulven/Prednisone, Irofulven/Capecitabine/Prednisone or Mitoxantrone/Prednisone in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer Patients

  Kuzel, T. M.

  MGI PHARMA, Inc.

  3/8/05 → 9/1/11

  Project: Research project